Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Collegium Pharmaceutical Inc shares valued at $814,180 were sold by Kuhlmann Shirley R. on Jun 03 ’24. At $32.57 per share, Kuhlmann Shirley R. sold 25,000 shares. The insider’s holdings dropped to 139,409 shares worth approximately $4.48 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Tupper Colleen sold 19,710 shares, netting a total of over 674,368 in proceeds. Following the sale of shares at $34.21 each, the insider now holds 130,845 shares.
Before that, Dreyer Scott had sold 56,807 shares from its account. In a trade valued at $1,930,455, the EVP & Chief Commercial Officer traded Collegium Pharmaceutical Inc shares for $33.98 each. Upon closing the transaction, the insider’s holdings decreased to 56,807 shares, worth approximately $3.4 million.
As published in a research note from Jefferies on June 07, 2024, Collegium Pharmaceutical Inc [COLL] has been rated up from a Hold to a Buy and the price target has been revised to $44 from $41. Analysts at Piper Sandler downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in early May. As of May 10, 2024, Needham has decreased its “Buy” rating to a “Hold” for COLL. Earlier on January 04, 2024, Jefferies downgraded its rating. Their new recommendation was “a Hold” for COLL stock which previously was a “a Buy”.
Analyzing COLL Stock Performance
During the last five days, there has been a drop of approximately -1.29%. Over the course of the year, Collegium Pharmaceutical Inc shares have jumped approximately 4.45%. Shares of the company reached a 52-week high of $40.95 on 03/28/24 and a 52-week low of $30.42 on 05/10/24. A 50-day SMA is recorded $34.52, while a 200-day SMA reached $30.66. Nevertheless, trading volume fell to 0.85 million shares from 0.3 million shares the previous day.
Support And Resistance Levels for Collegium Pharmaceutical Inc (COLL)
According to the 24-hour chart, there is a support level at 31.55, which, if violated, would cause prices to drop to 30.96. In the upper region, resistance lies at 32.47. The next price resistance is at 32.79. RSI (Relative Strength Index) is 43.47 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.30, which suggests the price will decrease in the coming days. Percent R is at 56.79%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
